Area of research
Genetics · Cognitive Neuroscience
Research interest
Research focused on Rituximab and Azacitidine, with related work in Myeloid leukemia, Oxaliplatin, Diffuse large B-cell lymphoma. Notable publications include 'Magrolimab plus azacitidine vs physician’s choice for untreated TP53 -mutated acute myeloid leukemia: the ENHANCE-2 study', 'Magrolimab plus rituximab in relapsed/refractory indolent non-Hodgkin lymphoma: 3-year follow-up of a phase 1/2 trial', and 'Magrolimab plus rituximab with or without chemotherapy in patients with relapsed/refractory diffuse large B-cell lymphoma'.